Multiple cycles of rituximab therapy for pemphigus: a group of patients with difficult‐to‐treat disease or a consequence of late rituximab initiation?
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult-to-treat disease or a consequence of late rituximab initiation?
K Balighi, P Hatami, MJS Aboli… - Dermatologic …, 2022 - pubmed.ncbi.nlm.nih.gov
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐to‐treat disease or a consequence of late rituximab initiation?
K Balighi, P Hatami, MJ Sheikh Aboli… - Dermatologic …, 2022 - search.ebscohost.com
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult-to-treat disease or a consequence of late rituximab initiation?
K Balighi, P Hatami, SA MJ… - Dermatologic …, 2021 - europepmc.org
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …